Pfizer Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pfizer Ltd. on BSE

Load latest

Pfizer Ltd.

31 Mar 2025

5260.50

-0.31%

SAST

Pfizer Ltd - 500680 - Closure of Trading Window

BSE India

We would like to inform you that the trading window of the Company shall remain closed from March 31, 2025 (close of business) till 48 hours after Audited Financial Results for the year ending March 31, 2025 are made public.

pdf

Pfizer Ltd.

29 Mar 2025, 08:47PM

5260.50

-0.31%

Company Update

Pfizer Ltd - 500680 - Update On Transfer And Assignment Of Pfizer'S Unexpired Leasehold Rights In …

BSE India

Update on Transfer and Assignment of MIDC Land and Buildings constructed thereon.

pdf

Pfizer Ltd.

19 Mar 2025

5260.50

-0.31%

SAST

Pfizer Ltd - 500680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

pdf

Pfizer Ltd.

21 Feb 2025

5260.50

-0.31%

Corp. Note

PFIZER LTD. - 500680 - Board Meeting Outcome for Marketing And Supply Agreement With Mylan Pharmaceuticals …

BSE India

Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board of Directors of the Company at their Meeting held today, that commenced on February 20, 2025 at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today, to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane.

pdf